20 LATEST RESOURCES (8 INDEXED)
×
Economic Evaluations of Opioid Use Disorder Interventions: A Systematic Review · September 2016
Articles (Manuscripts-Versions)
PubMed Central>PharmacoEconomics
×
Cost-Utility Analysis of Lurasidone versus Aripiprazole in Adults with Schizophrenia · April 2016
Articles
PharmacoEconomics
×
Cost Effectiveness of Paliperidone Long-Acting Injectable versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France · February 2016
Articles
PharmacoEconomics
×
The Economic Burden of Obesity by Glycemic Stage in the United States · January 2015
Articles
PharmacoEconomics
×
Cost-Effectiveness Analysis of Pharmaceutical Treatment Options in the First-Line Management of Major Depressive Disorder in Belgium · February 2014
Articles
PharmacoEconomics
×
Escitalopram and Duloxetine in Major Depressive Disorder: A Pharmacoeconomic Comparison Using UK Cost Data (NHS Economic Evaluation Database) · November 2008
Abstracts
University of York>Pharmacoeconomics
×
Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study (NHS Economic Evaluation Database) · April 2008
Abstracts
University of York>Pharmacoeconomics
×
Cost Effectiveness of Acute Imipramine Therapy versus Two Imipramine Maintenance Treatment Regimens for Panic Disorder (NHS Economic Evaluation Database) · October 2000
Abstracts
University of York>Pharmacoeconomics